Amended and RESTATED Director NOMINATION Agreement
Execution Version
Exhibit 10.1
Execution Version
Amended and RESTATED
THIS AMENDED AND RESTATED Director NOMINATION Agreement (this “Agreement”) is made and entered into as of April 26, 2021, by and among Agiliti, Inc., a Delaware corporation (the “Company”), and THL Agiliti LLC, a Delaware limited liability company (“THL Stockholder”). This Agreement shall become effective (the “Effective Date”) upon the closing of the Company’s initial public offering (the “IPO”) of shares of its common stock, par value $0.0001 per share (the “Common Stock”).
WHEREAS, as of the date hereof, THL Stockholder and the Company are parties to that certain Director Nomination Agreement, dated as of January 4, 2019 (the “Existing Agreement”);
WHEREAS, as of the date hereof, THL Stockholder owns more than 99% of the Common Stock of the Company;
WHEREAS, THL Stockholder is contemplating causing the Company to effect the IPO;
WHEREAS, in consideration of THL Stockholder agreeing to undertake the IPO, the Company has agreed to continue to permit THL Stockholder to designate persons for nomination for election to the board of directors of the Company (the “Board”) following the Effective Date on the terms and conditions set forth herein; and
WHEREAS, in connection with, and effective upon, the consummation of the IPO, the Company and THL Stockholder wish to amend and restate the Existing Agreement in its entirety as set forth herein.
NOW, THEREFORE, in consideration of the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, each of the parties to this Agreement agrees as follows:
1. | Board Nomination Rights. |
2
3
0.Xxxxxxx Obligations. The Company agrees to use its reasonable best efforts to ensure that prior to the date that THL Stockholder ceases to Beneficially Own shares of Common Stock representing at least 5% of the total voting power of the then outstanding Common Stock, (i) each Nominee is included in the Board’s slate of nominees to the stockholders (the “Board’s Slate”) for each election of directors; and (ii) each Nominee is included in the proxy statement prepared by management of the Company in connection with soliciting proxies for every meeting of the stockholders of the Company called with respect to the election of members of the Board (each, a “Director Election Proxy Statement”), and at every adjournment or postponement thereof, and on every action or approval by written consent of the stockholders of the Company or the Board with respect to the election of members of the Board. THL Stockholder will promptly provide reporting to the Company after THL Stockholder ceases to Beneficially Own shares of Common Stock representing at least 5% of the total voting power of the then outstanding Common Stock, such that Company is informed of when this obligation terminates. The calculation of the number of Nominees that THL Stockholder is entitled to nominate to the Board’s Slate for any election of directors shall be based on the percentage of the total voting power of the then outstanding Common Stock then Beneficially Owned by THL Stockholder (“THL Stockholder Voting Control”) immediately prior to the mailing to shareholders of the Director Election Proxy Statement relating to such election (or, if earlier, the filing of the definitive Director Election Proxy Statement with the U.S. Securities and Exchange Commission). Unless THL Stockholder notifies the Company otherwise prior to the mailing to shareholders of the Director Election Proxy
4
Statement relating to an election of directors, the Nominees for such election shall be presumed to be the same Nominees currently serving on the Board, and no further action shall be required of THL Stockholder for the Board to include such Nominees on the Board’s Slate; provided, that, in the event THL Stockholder is no longer entitled to nominate the full number of Nominees then serving on the Board, THL Stockholder shall provide advance written notice to the Company, of which currently servicing Nominee(s) shall be excluded from the Board Slate, and of any other changes to the list of Nominees. If THL Stockholder fails to provide such notice prior to the mailing to shareholders of the Director Election Proxy Statement relating to such election (or, if earlier, the filing of the definitive Director Election Proxy Statement with the U.S. Securities and Exchange Commission), a majority of the independent directors then serving on the Board shall determine which of the Nominees of THL Stockholder then serving on the Board will be included in the Board’s Slate. Furthermore, the Company agrees for so long as the Company qualifies as a “controlled company” under the rules of the Exchange the Company will elect to be a “controlled company” for purposes of the Exchange and will disclose in its annual meeting proxy statement that it is a “controlled company” and the basis for that determination. The Company and THL Stockholder acknowledge and agree that, as of the Effective Date, the Company is a “controlled company.”
3.Committees. From and after the Effective Date hereof until such time as THL Stockholder ceases to Beneficially Own shares of Common Stock representing at least 5% of the total voting power of the then outstanding Common Stock, THL Stockholder shall have the right to designate a number of members of each committee of the Board equal to the nearest whole number greater than the product obtained by multiplying (a) the percentage of the total voting power of the then outstanding Common Stock then Beneficially Owned by THL Stockholder and (b) the number of positions, including any vacancies, on the applicable committee, provided that any such designee shall be a director and shall be eligible to serve on the applicable committee under applicable law or listing standards of the Exchange, including any applicable independence requirements (subject in each case to any applicable exceptions, including those for newly public companies and for “controlled companies,” and any applicable phase-in periods). Any additional members shall be determined by the Board. Nominees designated to serve on a Board committee shall have the right to remain on such committee until the next election of directors, regardless of the level of THL Stockholder Voting Control following such designation. Unless THL Stockholder notifies the Company otherwise prior to the time the Board takes action to change the composition of a Board committee, and to the extent THL Stockholder has the requisite THL Stockholder Voting Control for THL Stockholder to nominate a Board committee member at the time the Board takes action to change the composition of any such Board committee, any Nominee currently designated by THL Stockholder to serve on a committee shall be presumed to be re-designated for such committee.
4.Amendment and Waiver. Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and is signed, in the case of an amendment, by the Company and THL Stockholder, or in the case of a waiver, by the party against whom the waiver is to be effective. No failure or delay by any party in exercising any right, power or privilege hereunder shall operate as a waiver thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any
5
rights or remedies provided by law. THL Stockholder shall not be obligated to nominate all (or any) of the Nominees it is entitled to nominate pursuant to this Agreement for any election of directors but the failure to do so shall not constitute a waiver of its rights hereunder with respect to future elections; provided, however, that in the event THL Stockholder fails to nominate all (or any) of the Nominees it is entitled to nominate pursuant to this Agreement prior to the mailing to shareholders of the Director Election Proxy Statement relating to such election (or, if earlier, the filing of the definitive Director Election Proxy Statement with the U.S. Securities and Exchange Commission), the Compensation and Governance Committee of the Board shall be entitled to nominate individuals in lieu of such Nominees for inclusion in the Board’s Slate and the applicable Director Election Proxy Statement with respect to the election for which such failure occurred and THL Stockholder shall be deemed to have waived its rights hereunder with respect to such election. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or remedies provided by law.
7. | Indemnity. |
6
7
8
If to the Company:
0000 Xxxx 00xx Xxxxxx, Xxxxx 000
Xxxxxxxxxxx, Xxxxxxxxx 00000-0000
Attention: General Counsel and Secretary
Facsimile: (000) 000-0000
If to THL Stockholder or any Nominee:
000 Xxxxxxx Xxxxxx, 00xx Xxxxx
Xxxxxx, Xxxxxxxxxxxxx 00000
Attention: Xxxxxx X. Xxxxx
Facsimile: (000) 000-0000
With a copy to (which shall not constitute notice):
Xxxxxxxx & Xxxxx LLP
000 X. XxXxxxx
Xxxxxxx, XX 00000
Attention: Xxxxxx X. Xxxxxxx, P.C.
Xxxxxxxxx X. Xxxxxxxx
Facsimile: (000) 000-0000
or to such other address or telecopier number as such party or the Company may hereafter specify for the purpose by notice to the other parties and the Company. Each such notice, request or other communication shall be effective when delivered at the address specified in this Section 16 during regular business hours.
9
* * * * *
10
IN WITNESS WHEREOF, the parties hereto have executed this Agreement on the date first above written.
AGILITI, INC.
By:/s/ Xxxxxx X. Leonard__________________
Name: Xxxxxx X. Xxxxxxx
Title: Chief Executive Officer
A&R Director Nomination Agreement - Agiliti
THL AGILITI, LLC
By: /s/ Xxxxxx X. Nelson________________________
Name: Xxxxxx X. Xxxxxx
Title: Managing Director
A&R Director Nomination Agreement - Agiliti